| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 5.55e-05 | 6 | 39 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.03e-04 | 8 | 39 | 2 | GO:0032453 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 1.09e-05 | 156 | 39 | 5 | GO:0048259 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 3.07e-05 | 95 | 39 | 4 | GO:0002090 | |
| Domain | Lys_sp_deMease-like_dom | 2.54e-05 | 4 | 39 | 2 | IPR013637 | |
| Domain | PLU-1 | 2.54e-05 | 4 | 39 | 2 | PF08429 | |
| Domain | zf-C5HC2 | 4.23e-05 | 5 | 39 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 4.23e-05 | 5 | 39 | 2 | IPR004198 | |
| Domain | JmjN | 1.89e-04 | 10 | 39 | 2 | PF02375 | |
| Domain | JmjN | 1.89e-04 | 10 | 39 | 2 | SM00545 | |
| Domain | JMJN | 1.89e-04 | 10 | 39 | 2 | PS51183 | |
| Domain | JmjN | 1.89e-04 | 10 | 39 | 2 | IPR003349 | |
| Domain | - | 4.39e-04 | 15 | 39 | 2 | 1.10.150.60 | |
| Domain | ARID | 4.39e-04 | 15 | 39 | 2 | PF01388 | |
| Domain | BRIGHT | 4.39e-04 | 15 | 39 | 2 | SM00501 | |
| Domain | ARID_dom | 4.39e-04 | 15 | 39 | 2 | IPR001606 | |
| Domain | ARID | 4.39e-04 | 15 | 39 | 2 | PS51011 | |
| Domain | JmjC | 1.14e-03 | 24 | 39 | 2 | PF02373 | |
| Domain | JMJC | 2.03e-03 | 32 | 39 | 2 | PS51184 | |
| Domain | JmjC_dom | 2.03e-03 | 32 | 39 | 2 | IPR003347 | |
| Domain | JmjC | 2.15e-03 | 33 | 39 | 2 | SM00558 | |
| Domain | Znf_RING/FYVE/PHD | 2.54e-03 | 459 | 39 | 5 | IPR013083 | |
| Domain | Zinc_finger_PHD-type_CS | 8.13e-03 | 65 | 39 | 2 | IPR019786 | |
| Domain | PHD | 1.07e-02 | 75 | 39 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 1.18e-02 | 79 | 39 | 2 | IPR019787 | |
| Domain | - | 1.40e-02 | 449 | 39 | 4 | 3.30.40.10 | |
| Domain | SAM | 1.45e-02 | 88 | 39 | 2 | SM00454 | |
| Domain | PHD | 1.48e-02 | 89 | 39 | 2 | SM00249 | |
| Domain | Znf_PHD | 1.55e-02 | 91 | 39 | 2 | IPR001965 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18460473 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 38230606 | ||
| Pubmed | RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. | 4.06e-06 | 3 | 41 | 2 | 17320161 | |
| Pubmed | KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas. | 4.06e-06 | 3 | 41 | 2 | 37880235 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 26645689 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16929535 | ||
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 8.12e-06 | 4 | 41 | 2 | 16541399 | |
| Pubmed | Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. | 2.03e-05 | 6 | 41 | 2 | 21960634 | |
| Pubmed | Identification of FANCA as a protein interacting with centromere-associated protein E. | 2.84e-05 | 7 | 41 | 2 | 19779646 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 36357400 | ||
| Pubmed | Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. | 7.41e-05 | 11 | 41 | 2 | 15949438 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 9.21e-05 | 922 | 41 | 7 | 27609421 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 24619213 | ||
| Pubmed | 1.09e-04 | 1285 | 41 | 8 | 35914814 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.14e-04 | 212 | 41 | 4 | 33853758 | |
| Pubmed | 1.66e-04 | 234 | 41 | 4 | 36243803 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.82e-04 | 17 | 41 | 2 | 20639394 | |
| Pubmed | A physical map of the genomic region on mouse chromosome 3 containing the hindshaker (hsh) mutation. | 2.29e-04 | 19 | 41 | 2 | 14706451 | |
| Pubmed | 2.29e-04 | 19 | 41 | 2 | 25263594 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 23637629 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.64e-04 | 264 | 41 | 4 | 32814769 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 2.81e-04 | 21 | 41 | 2 | 27626377 | |
| Pubmed | 2.86e-04 | 497 | 41 | 5 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.86e-04 | 497 | 41 | 5 | 36774506 | |
| Pubmed | 2.98e-04 | 1116 | 41 | 7 | 31753913 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 20696395 | ||
| Pubmed | 3.38e-04 | 23 | 41 | 2 | 19240791 | ||
| Pubmed | Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. | 3.68e-04 | 24 | 41 | 2 | 20705733 | |
| Pubmed | 4.11e-04 | 538 | 41 | 5 | 28524877 | ||
| Pubmed | 4.27e-04 | 124 | 41 | 3 | 35516420 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.74e-04 | 857 | 41 | 6 | 25609649 | |
| Pubmed | 6.17e-04 | 31 | 41 | 2 | 25996949 | ||
| Pubmed | 6.25e-04 | 332 | 41 | 4 | 37433992 | ||
| Pubmed | A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. | 6.58e-04 | 32 | 41 | 2 | 24192035 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 7.00e-04 | 33 | 41 | 2 | 26864203 | |
| Pubmed | 7.30e-04 | 1297 | 41 | 7 | 33545068 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 8.71e-04 | 363 | 41 | 4 | 14691545 | |
| Pubmed | 8.72e-04 | 963 | 41 | 6 | 28671696 | ||
| Pubmed | 9.10e-04 | 971 | 41 | 6 | 33306668 | ||
| GeneFamily | AT-rich interaction domain containing | 2.76e-04 | 15 | 30 | 2 | 418 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 7.18e-04 | 24 | 30 | 2 | 485 | |
| Coexpression | DESCARTES_MAIN_FETAL_BIPOLAR_CELLS | 1.48e-05 | 95 | 41 | 4 | M40097 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 2.59e-05 | 187 | 41 | 4 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 192 | 41 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.12e-05 | 196 | 41 | 4 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.37e-05 | 200 | 41 | 4 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.74e-04 | 118 | 41 | 3 | 9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.13e-04 | 144 | 41 | 3 | 9d6133558728fa148050eb4f0be33756d71310b0 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.26e-04 | 146 | 41 | 3 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-04 | 146 | 41 | 3 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-04 | 153 | 41 | 3 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.95e-04 | 32 | 41 | 2 | ba89b22a5ce8ee9f3099b1fa84721724b94c7759 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.95e-04 | 32 | 41 | 2 | 58b212d4f2955f06a195df0f79ad95a8ff145b83 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 4.34e-04 | 161 | 41 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.58e-04 | 164 | 41 | 3 | 4a4c32d242db97216cb345e59865c2c826c8b9f2 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 4.58e-04 | 164 | 41 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-04 | 166 | 41 | 3 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.91e-04 | 168 | 41 | 3 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-04 | 171 | 41 | 3 | 2c7d73f1386ddd172839734c68ed3859a90f80f8 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 5.35e-04 | 173 | 41 | 3 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.53e-04 | 175 | 41 | 3 | 06eace2e681980456299167b48bd49bcfea5e940 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-04 | 180 | 41 | 3 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-04 | 180 | 41 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-04 | 180 | 41 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.10e-04 | 181 | 41 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-04 | 181 | 41 | 3 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-04 | 182 | 41 | 3 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-04 | 182 | 41 | 3 | 9d727ab84da8de33f1021b492c90d8b4c2a8ea23 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-04 | 182 | 41 | 3 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-04 | 182 | 41 | 3 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-04 | 182 | 41 | 3 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.40e-04 | 184 | 41 | 3 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.40e-04 | 184 | 41 | 3 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 6.50e-04 | 185 | 41 | 3 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.50e-04 | 185 | 41 | 3 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.50e-04 | 185 | 41 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.50e-04 | 185 | 41 | 3 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.50e-04 | 185 | 41 | 3 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.60e-04 | 186 | 41 | 3 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-04 | 186 | 41 | 3 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 6.71e-04 | 187 | 41 | 3 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-04 | 187 | 41 | 3 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.71e-04 | 187 | 41 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-04 | 187 | 41 | 3 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-04 | 187 | 41 | 3 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.71e-04 | 187 | 41 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 6.81e-04 | 188 | 41 | 3 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.81e-04 | 188 | 41 | 3 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.81e-04 | 188 | 41 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 6.92e-04 | 189 | 41 | 3 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-04 | 189 | 41 | 3 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-04 | 189 | 41 | 3 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-04 | 189 | 41 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-04 | 189 | 41 | 3 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-04 | 189 | 41 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.92e-04 | 189 | 41 | 3 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-04 | 190 | 41 | 3 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.02e-04 | 190 | 41 | 3 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-04 | 190 | 41 | 3 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-04 | 190 | 41 | 3 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-04 | 190 | 41 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-04 | 190 | 41 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.13e-04 | 191 | 41 | 3 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-04 | 191 | 41 | 3 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-04 | 191 | 41 | 3 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.13e-04 | 191 | 41 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 7.13e-04 | 191 | 41 | 3 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-04 | 191 | 41 | 3 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-04 | 191 | 41 | 3 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-04 | 191 | 41 | 3 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.13e-04 | 191 | 41 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-04 | 191 | 41 | 3 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.24e-04 | 192 | 41 | 3 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.24e-04 | 192 | 41 | 3 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.24e-04 | 192 | 41 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.24e-04 | 192 | 41 | 3 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.24e-04 | 192 | 41 | 3 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.24e-04 | 192 | 41 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.24e-04 | 192 | 41 | 3 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.35e-04 | 193 | 41 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.35e-04 | 193 | 41 | 3 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.35e-04 | 193 | 41 | 3 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.35e-04 | 193 | 41 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-04 | 193 | 41 | 3 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-04 | 193 | 41 | 3 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.35e-04 | 193 | 41 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.46e-04 | 194 | 41 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-04 | 194 | 41 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.46e-04 | 194 | 41 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.46e-04 | 194 | 41 | 3 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.02e-05 | 4 | 39 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | X-21448 measurement | 7.61e-05 | 10 | 39 | 2 | EFO_0800816 | |
| Disease | FEV/FEC ratio | 1.71e-04 | 1228 | 39 | 8 | EFO_0004713 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.02e-04 | 16 | 39 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | freckles | 3.19e-04 | 20 | 39 | 2 | EFO_0003963 | |
| Disease | suntan | 3.45e-04 | 103 | 39 | 3 | EFO_0004279 | |
| Disease | HIV Coinfection | 3.45e-04 | 103 | 39 | 3 | C4505456 | |
| Disease | HIV Infections | 3.45e-04 | 103 | 39 | 3 | C0019693 | |
| Disease | nephrolithiasis | 8.76e-04 | 33 | 39 | 2 | EFO_0004253 | |
| Disease | Parkinson disease, disease progression measurement | 1.22e-03 | 39 | 39 | 2 | EFO_0008336, MONDO_0005180 | |
| Disease | response to hydrochlorothiazide, fasting blood glucose measurement | 1.70e-03 | 46 | 39 | 2 | EFO_0004465, EFO_0005202 | |
| Disease | breast cancer (is_marker_for) | 1.88e-03 | 185 | 39 | 3 | DOID:1612 (is_marker_for) | |
| Disease | susceptibility to bacterial meningitis measurement | 2.16e-03 | 52 | 39 | 2 | EFO_0008411 | |
| Disease | hypertension, white matter hyperintensity measurement | 3.06e-03 | 62 | 39 | 2 | EFO_0000537, EFO_0005665 | |
| Disease | urolithiasis | 3.16e-03 | 63 | 39 | 2 | MONDO_0024647 | |
| Disease | cortical thickness | 3.19e-03 | 1113 | 39 | 6 | EFO_0004840 | |
| Disease | body fat percentage | 3.85e-03 | 488 | 39 | 4 | EFO_0007800 | |
| Disease | intellectual disability (implicated_via_orthology) | 4.44e-03 | 75 | 39 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | non-melanoma skin carcinoma | 5.16e-03 | 265 | 39 | 3 | EFO_0009260 | |
| Disease | hormone measurement | 5.54e-03 | 84 | 39 | 2 | EFO_0004730 | |
| Disease | small vessel stroke | 7.18e-03 | 96 | 39 | 2 | EFO_1001504 | |
| Disease | sunburn | 7.18e-03 | 96 | 39 | 2 | EFO_0003958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLLTTNSDHMTFMQR | 196 | P35503 | |
| MQRPHRRQSQMDAAS | 1 | A8MWP4 | |
| NMMFSSVRSRNRHSQ | 1071 | Q6ZN30 | |
| VTIRNVSRHIQMSLM | 11 | Q8N7U9 | |
| HMSPRVVNRMSRFQK | 446 | Q9H6U6 | |
| QSIQRNMSAMERFRN | 291 | Q92747 | |
| FRNISRIMRVNNSTM | 81 | P28070 | |
| AHLTNQYMQRMASVR | 376 | P11940 | |
| RTRQMNTRSSAQDMP | 171 | Q9Y4X5 | |
| HETMAQVLFSRNMRL | 151 | Q9H079 | |
| QLRSQTRLHMSNMSD | 466 | O43300 | |
| SMIRRMHLNGSNVQV | 3081 | Q07954 | |
| FRMQLHTRMSNRRVV | 151 | Q92633 | |
| NSQIHMIAQRRDAMA | 126 | O95447 | |
| RKVTNRSDAFNMQMR | 266 | P29375 | |
| NSQRSQLMMRTRIAA | 71 | Q9BW72 | |
| HVMLNRNSSNMLRTN | 441 | Q6AI39 | |
| RMKMVSQSFTQRFRL | 336 | Q9Y5N1 | |
| MQMAVSRVIRLQHHR | 881 | Q16760 | |
| VVQLHMNRTAMRASQ | 26 | O75521 | |
| RMQMHSLRLLSQNQP | 261 | Q9NS85 | |
| MVQSANSHVRRLMNE | 306 | Q8TC92 | |
| MNQRSSRSHTIFRMI | 196 | Q02224 | |
| IQLFETQRVRHGMMT | 2246 | Q8TE73 | |
| RFEQAQHMFRQAMRT | 336 | Q8TEW0 | |
| MLLINSLRRHTQRMQ | 201 | P59536 | |
| MNSQNSGFTQRRRMA | 56 | Q8WV83 | |
| RNEMIQRHHTARTEM | 86 | Q7Z3H4 | |
| NRIQMRSLQQQFSRM | 101 | O14513 | |
| MAMFRSLVASAQQRQ | 1 | Q96A37 | |
| ISNLSMQTHAARMRT | 261 | Q13490 | |
| SMQRFHNRVRQILMA | 1236 | Q6P2Q9 | |
| DFTILRNMLIRTHMQ | 281 | Q16181 | |
| RTLTVQYRMHQAIMR | 436 | P38935 | |
| RHMRMTRSVDNVQFL | 31 | Q9BRV3 | |
| AHRENMRQMIRSFSE | 21 | P58340 | |
| FRVRSILLNHQMMHT | 686 | Q6ZN19 | |
| RQTRRNHLFTMMNVT | 871 | O43149 | |
| RSMTLRCTQDMRHNA | 36 | A0A1B0GX49 | |
| QQITMEMSALRTHRI | 1096 | Q9H2Y7 | |
| MLRNSTFKNMQRRHT | 1 | Q9HCX4 | |
| TKMTMRLRRNHSNAQ | 306 | P41229 |